Effects of Insulin Glargine and Lixisenatide on the Brain

NCT03881995 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped insufficient recruitment

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: IGlarLixi
DRUG: Insulin Glargine 100 UNT/ML

Sponsor

University Hospital Tuebingen